Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39142

DNAJB4 Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

This polyclonal knockout cell product consists of Raji B lymphocytes with CRISPR/Cas9-mediated disruption of the DNAJB4 gene. DNAJB4, an Hsp40 co-chaperone, activates Hsp70 to regulate protein folding and ER stress, and mediates p53-dependent tumor suppression by inducing apoptosis and cell cycle arrest. The host Raji line is an EBV-positive Burkitt??s lymphoma B cell model used extensively in immunology and oncology. The polyclonal pool supports studies of DNAJB4??s role in chaperone biology, p53 signaling, and ER stress in B-cell lymphoma. It enables Western blotting, apoptosis assays, co-immunoprecipitation, and drug screening. Key interactors include Hsp70, p53, p21, BAX, and STUB1/CHIP.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    DNAJB4

    Gene Identifier

    NCBI Gene ID 11080

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAJB4 Knockout Raji Polyclonal Cells consist of a Raji B lymphocyte population with CRISPR/Cas9-mediated disruption of the DNAJB4 gene. This polyclonal knockout cell pool, generated without single-cell cloning, retains diverse editing events across the bulk culture, providing a heterogeneous loss-of-function model.

Raji is a human Burkitt??s lymphoma B cell line, EBV-positive, extensively used in immunology and cancer research. These B lymphocytes are characterized by robust immunoglobulin production, antigen presentation, and high proliferative capacity, making them a relevant system for studying lymphomagenesis and B-cell signaling.

DNAJB4 encodes an Hsp40 co-chaperone that activates Hsp70 (HSPA1A) and Hsc70 (HSPA8) ATPase activity, facilitating protein folding, degradation, and ER stress responses. As a p53 target gene, DNAJB4 exerts tumor-suppressive functions by promoting apoptosis via BAX upregulation and cell cycle arrest through p21 induction, while inhibiting EGFR-mediated proliferation and migration. DNAJB4 is transcriptionally regulated by HSF1 under heat shock and participates in the UPR downstream of PERK, IRE1, and ATF6. It also cooperates with STUB1/CHIP to target misfolded substrates for proteasomal clearance, linking chaperone machinery to p53-driven apoptosis and protein quality control.

In the Raji B-cell lymphoma context, DNAJB4 knockout enables dissection of co-chaperone function in malignant B lymphocyte biology, including ER stress adaptation, apoptotic resistance, and EBV-driven proliferation. The polyclonal knockout population recovers a range of editing events, mirroring intratumoral heterogeneity and allowing genotype?Cphenotype correlation without clonal bias. Additionally, Raji cells?? active antibody secretion and antigen presentation facilitate studies on the role of chaperones in immunoglobulin biosynthesis and immune recognition.

Research applications include Western blotting and RT-qPCR to confirm DNAJB4 loss and evaluate downstream targets (p21, BAX), co-immunoprecipitation to probe Hsp70?Cclient interactions, and flow cytometric Annexin V assays for apoptosis quantification. Tunicamycin-induced ER stress assays reveal DNAJB4??s role in UPR regulation, while migration and proliferation assays measure its impact on tumor cell behavior. The model also supports small-molecule screening for agents targeting proteotoxic stress or p53 reactivation in B-cell malignancies. For technical inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)